BOULDER, Colo., Sept. 24, 2025 /PRNewswire/ — BranchLab today announced the formation of its Scientific Advisory Board, bringing two of the country’s leading AI academic researchers into its work at the intersection of artificial intelligence and population health. The Board’s founding members are:
The Scientific Advisory Board will support BranchLab’s mission by advising on methodological innovation and helping identify high impact‑ applications of its technologies.
“This advisory board ensures we stay deeply connected to the cutting edge of AI research,” said Kat Drake, PhD, Vice President of Data Science and AI at BranchLab. “Their insight will sharpen our thinking and accelerate our ability to translate innovation into real world‑ healthcare impact.”
The Board reflects BranchLab’s commitment to scientific rigor and privacy forward‑ innovation in healthcare data modeling.
About BranchLab
BranchLab is an AI-native technology company setting a new standard in privacy-first, outcome-based advertising for healthcare. Its platform, Pathwai™ enables brands, agencies, and media partners to design, activate, and measure audiences optimized to real-world outcomes such as prescriptions, diagnoses, or healthcare visits using non-health data. BranchLab operates in the United States with offices in New York, Colorado and San Francisco. For more information, visit www.branchlab.com.
Media Contact
press@branchlab.com
SOURCE BranchLab Inc
Registration Link for Phio's Presentation on Thursday, January 22 at 1:45 PM ETKing of Prussia,…
WASHINGTON, D.C. / ACCESS Newswire / January 15, 2026 / The American Medical Informatics Association…
CID-103 is a potential best-in-class, anti-CD38 monoclonal antibody; binds to unique CD38 epitopeAMR is a…
Multi-year wins underscore sustained specialty-first innovation, workflow depth, and revenue-cycle performance at scale TAMPA, FLORIDA…
First of its kind in the UK as medical cannabis patients get on-demand legal support…
NOTTINGHAM, UK / ACCESS Newswire / January 15, 2026 / First of its kind in…